Drug Trials Snapshots: WINREVAIR
Summary
WINREVAIR is indicated for the treatment of adults with pulmonary arterial hypertension (PAH, WHO group 1) to increase exercise capacity, improve function, and ...
Description
WINREVAIR is indicated for the treatment of adults with pulmonary arterial hypertension (PAH, WHO group 1) to increase exercise capacity, improve function, and ...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source